Civic Intelligence

Washington State Pharmaceutical Foundation

990 • Fiscal year 2012 • EIN 91-0996629

Jan 01, 2012 to Dec 31, 2012

Renton, WA
Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

47th percentile

0.04x

Higher debt load relative to assets than 47% of similar nonprofits.

2012 filings • 501(c)3 • $500k-$1M nonprofits • Source year 2012

Liabilities / Revenue

81st percentile

0.44x

Higher debt load relative to revenue than 81% of similar nonprofits.

2012 filings • 501(c)3 • $500k-$1M nonprofits • Source year 2012

Net Margin

63rd percentile

7.7%

Higher net margin than 63% of similar nonprofits.

2012 filings • 501(c)3 • $500k-$1M nonprofits • Source year 2012

Top Officer Pay

Score unavailable

No value available

This filing does not contain officer compensation rows.

Source year 2012

Asset Growth

41st percentile

-1.0%

Faster asset growth than 41% of similar nonprofits.

2012 filings • 501(c)3 • $500k-$1M nonprofits • Annualized from 2011 to 2012

Revenue Growth

73rd percentile

18%

Faster revenue growth than 73% of similar nonprofits.

2012 filings • 501(c)3 • $500k-$1M nonprofits • Annualized from 2011 to 2012

Assets

Down

$590,880

Down $6,021 (-1.0%) from 2011

Net Assets

Down

$565,636

Down $517 (-0.1%) from 2011

Liabilities

Down

$25,244

Down $5,504 (-18%) from 2011

Revenue

Up

$57,468

Up $8,874 (+18%) from 2011

Expenses

Down

$53,018

Down $12,348 (-19%) from 2011

Net Income

Up

$4,450

Up $21,222 (+127%) from 2011

Historical Trend

Balance Sheet Trend

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$1.5M$1.0M$500K$0Assets 2011: $596,901Liabilities 2011: $30,748Net Assets 2011: $566,1532011Assets 2012: $590,880Liabilities 2012: $25,244Net Assets 2012: $565,6362012Assets 2013: $599,378Liabilities 2013: $12,738Net Assets 2013: $586,6402013Assets 2014: $696,534Liabilities 2014: $24,800Net Assets 2014: $671,7342014Assets 2015: $678,468Liabilities 2015: $17,625Net Assets 2015: $660,8432015Assets 2016: $719,037Liabilities 2016: $24,800Net Assets 2016: $694,2372016Assets 2017: $758,218Liabilities 2017: $22,408Net Assets 2017: $735,8102017Assets 2018: $716,135Liabilities 2018: $24,800Net Assets 2018: $691,3352018Assets 2019: $791,632Liabilities 2019: $26,661Net Assets 2019: $764,9712019Assets 2020: $835,240Liabilities 2020: $24,800Net Assets 2020: $810,4402020Assets 2021: $940,931Liabilities 2021: $27,665Net Assets 2021: $913,2662021Assets 2022: $814,958Liabilities 2022: $34,554Net Assets 2022: $780,4042022Assets 2023: $942,090Liabilities 2023: $25,553Net Assets 2023: $916,5372023Assets 2024: $1,028,818Liabilities 2024: $24,800Net Assets 2024: $1,004,0182024

Highlighted filing

2012

Assets$590,880
Liabilities$25,244
Net Assets$565,636

Operations Trend

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$200K$100K$0-$100KRevenue 2011: $48,594Expenses 2011: $65,366Net Income 2011: -$16,7722011Revenue 2012: $57,468Expenses 2012: $53,018Net Income 2012: $4,4502012Revenue 2013: $89,957Expenses 2013: $68,953Net Income 2013: $21,0042013Revenue 2014: $154,783Expenses 2014: $45,749Net Income 2014: $109,0342014Revenue 2015: $41,693Expenses 2015: $57,553Net Income 2015: -$15,8602015Revenue 2016: $53,352Expenses 2016: $24,414Net Income 2016: $28,9382016Revenue 2017: $121,978Expenses 2017: $84,885Net Income 2017: $37,0932017Revenue 2018: $77,996Expenses 2018: $126,412Net Income 2018: -$48,4162018Revenue 2019: $87,478Expenses 2019: $13,841Net Income 2019: $73,6372019Revenue 2020: $67,607Expenses 2020: $22,138Net Income 2020: $45,4692020Revenue 2021: $119,713Expenses 2021: $17,058Net Income 2021: $102,6552021Revenue 2022: $39,095Expenses 2022: $29,978Net Income 2022: $9,1172022Revenue 2023: $62,781Expenses 2023: $10,254Net Income 2023: $52,5272023Revenue 2024: $28,936Expenses 2024: $35,986Net Income 2024: -$7,0502024

Highlighted filing

2012

Revenue$57,468
Expenses$53,018
Net Income$4,450
Filing Detail Status

This 2012 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.

Jump To
Filing Snapshot
Filing Period
Jan 1, 2012 to Dec 31, 2012
Mission and Program Overview

Mission

The Foundatiion exists to support and initiate educational programa, pharmacy practice research, and innovative practices to improve and enhance pharmacy practice.

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings

Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2024Facts available. Structured filing facts are available, but richer extracted sections are limited.$1.03$0.02$1.00$0.03$0.04$0.01
2023Detailed filing. Detailed filing data is available for this year.$0.94$0.03$0.92$0.06$0.01$0.05
2022Detailed filing. Detailed filing data is available for this year.$0.81$0.03$0.78$0.04$0.03$0.01
2021Detailed filing. Detailed filing data is available for this year.$0.94$0.03$0.91$0.12$0.02$0.10
2020Detailed filing. Detailed filing data is available for this year.$0.84$0.02$0.81$0.07$0.02$0.05
2019Detailed filing. Detailed filing data is available for this year.$0.79$0.03$0.76$0.09$0.01$0.07
2018Detailed filing. Detailed filing data is available for this year.$0.72$0.02$0.69$0.08$0.13$0.05
2017Detailed filing. Detailed filing data is available for this year.$0.76$0.02$0.74$0.12$0.08$0.04
2016Detailed filing. Detailed filing data is available for this year.$0.72$0.02$0.69$0.05$0.02$0.03
2015Detailed filing. Detailed filing data is available for this year.$0.68$0.02$0.66$0.04$0.06$0.02
2014Detailed filing. Detailed filing data is available for this year.$0.70$0.02$0.67$0.15$0.05$0.11
2013Detailed filing. Detailed filing data is available for this year.$0.60$0.01$0.59$0.09$0.07$0.02
2012Summary only. Only limited summary data is available for this year.$0.59$0.03$0.57$0.06$0.05$0.00
2011Summary only. Only limited summary data is available for this year.$0.60$0.03$0.57$0.05$0.07$0.02